EMEA Cardiovascular disease Growing number of coronary artery diseases

EMEA Cardiovascular disease

Cardiovascular disease (CVD) is the term used for ailments that affect the heart or blood vessels of the human body. When the fatty leftovers assemble in the arteries, they block the blood vessels and create blood clots that can become chronic. This process, in general, is called as atherosclerosis. There are also chances that arteries in other organs like brain, heart, kidneys and eyes can also get damaged with these ailments. CVDs are the one of the principal death and disability causing factors in the United Kingdom but can be avoided by maintaining a proper diet and lifestyle. Various factors like unhealthy lifestyle, heart rhythm complications, smoking, high cholesterol, lack of exercise, diabetes, obesity, poor diet, alcohol consumption and high blood pressure can result in CVDs. As per market statistics, 13% of CVD deaths were due to high blood pressure, 9% due to tobacco, 6% due to diabetes, 6% for lack of exercises and 5% for obesity.

Cardiovascular diseases include several diseases like angina, myocardial infarction (heart attack), peripheral arterial disease, stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis. Drug therapy (ACE inhibitors, antiarrhythmic, aspirin therapy, beta-blocker therapy, clot-buster drugs, diuretics, etc.), changes in lifestyle habits, and surgeries (stents, coronary stents, peripheral stents, heart bypass surgery, pacemakers, implantable cardioverter defibrillators, and heart transplants) are the various types treatments for CVDs. The implants used in the treatment of patients are made of items such as metals, alloys, biomaterials, and polymers, and helps improving the life expectancy of the patient.

Growing number of hypertension, heart failures and coronary artery diseases effected population and the lack of heart donors are the principal factors promoting the CVD implants market. Also, changing lifestyles of the people, alcohol and tobacco intake, and increasing cases of obesity are increasing the glucose and lipid levels, which causes cardiovascular diseases favouring the implants market. Around 5.5 million people have heart attacks in the US in 2013 and close to 0.3 million die every year due to heart failure, as per the report of American Heart Association publication. However, High-risk associated with the surgery and complications resulting in deaths owing to the increasing use of implants in elderly population is a main constraint for the rapid expansion of CVD implants market.

The global cardiovascular implants market is predicted to cross USD40 billion by 2024 with a growing CAGR of 5.8% during the forecast period between 2017e and 2024f, which was valued at USD26.5 billion in 2016.

European countries are next to Americas in terms of global share for cardiovascular implants market. The increasing investments for improving the healthcare infrastructure is promoting the market in the European countries like Germany, UK, France, Italy and Spain. Similarly, the growing awareness among the people of Middle East and Africa is also propelling the market demand for heart implants in the region.

Report Highlights:

The report delivers a strategic analysis of the global market for cardiovascular implants and growth forecast for the period from 2017e – 2024f. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of implants. It also covers geographical analysis of the market with growth forecast for the period of 2017e – 2024f. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.

The study also provides information for recent merger and acquisition deals happened in the global cardiovascular implants market. Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global cardiovascular implants market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies

Companies profiled:

The company profile section includes detailed analysis of some of the key players such as Abbott Laboratories, B-Braun, Boston Scientific, Medtronic plc., St. Jude Medical, Inc., C. R. Bard, Inc., Cook Medical, Terumo Corporation, Edwards Lifesciences, and AMG International.

Contact Author:
Anand Sai
Independent Research Consultant
Market Reports Web
sai@marketreportsweb.com

Be the first to comment

Leave a Reply